Hemoglobin Levels After Consuming the Initial Phase of Antitubercular Drugs

Susiwati, Susiwati and Muslim, Zamharira (2019) Hemoglobin Levels After Consuming the Initial Phase of Antitubercular Drugs. Asian Journal of Pharmaceutical and Clinical Research, 12 (6). pp. 113-114. ISSN 0974-2441

	Text Artikel Hemoglobin Levels After Consuming The Initial Phase Of Antitubercular Drugs.pdf Download (615kB)
	Text Peer Review Hemoglobin Levels After Consuming The Initial Phase Of Antitubercular Drugs.pdf Download (1MB)
	Text Similarity Hemoglobin Levels After Consuming The Initial Phase Of Antitubercular Drugs.pdf Download (580kB)

Abstract

Objective: This study aims to determine the condition of the hemoglobin (Hb) level after the initial phase of antitubercular drug usage. Methods: This research method used a descriptive survey design with the accidental sampling method. The sample of this study was 38 patients who met the inclusion criteria of the study. The sample was measured by Coulter Act-Diff Hematology Analyzer. Results: This study shows the initial phase of antitubercular drugs (ATD) usage caused an abnormal hemoglobin level of 22 patients (58%) and 16 patients (42%) have a normal level. There are 12 (32%) male and 10 (26%) female patients have an abnormal level of Hb. The average of Hb level in tuberculosis (TB) patients is 12.42 (male) and 11.89 (female). This study also shows the correlation between body mass index with a Hb level of TB patient (p=0.001). Conclusion: Hb levels in TB patients who consumed the initial phase of ATD were found to be mostly under normal.

Actions (login required)

View Item